Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor

Cancer Res. 1992 Nov 15;52(22):6310-7.

Abstract

A high percentage of human breast and ovarian tumors display amplified c-erbB-2 gene copies, leading to overexpression of the growth factor receptor. Its membrane location and elevated expression make the erbB-2 protein an appropriate target for a directed tumor therapy. We have used recombinant DNA technology to produce a single-chain antibody-exotoxin A (scFv-ETA) fusion protein which specifically binds the human erbB-2 receptor. The scFv portion is composed of the heavy- and light-chain variable domains of a monoclonal antibody which recognizes the extracellular domain of the human erbB-2 receptor. The bacterially produced scFv-ETA protein was shown to bind specifically to cells expressing the human erbB-2 protein. The scFv-ETA inhibits protein synthesis in erbB-2-expressing tumor cells at doses ranging from 2 to 200 ng/ml and is cytotoxic for these cells at equivalent doses. In athymic nude mice, administration of the scFv-ETA inhibited the growth of erbB-2-overexpressing human ovarian carcinoma cells.

MeSH terms

  • ADP Ribose Transferases*
  • Amino Acid Sequence
  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibody Specificity
  • Bacterial Toxins*
  • Base Sequence
  • Carrier Proteins / genetics
  • Carrier Proteins / pharmacology*
  • Cell Division / drug effects
  • Chimera / genetics
  • DNA, Recombinant / genetics
  • Exotoxins / genetics
  • Exotoxins / pharmacology*
  • Female
  • Humans
  • Immunotoxins / pharmacology*
  • Mammary Neoplasms, Experimental / drug therapy
  • Mammary Neoplasms, Experimental / immunology
  • Mammary Neoplasms, Experimental / therapy*
  • Mice
  • Mice, Nude
  • Molecular Sequence Data
  • Neoplasm Proteins / biosynthesis
  • Neoplasm Transplantation
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / immunology
  • Ovarian Neoplasms / therapy*
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins / immunology*
  • Proto-Oncogene Proteins / physiology
  • Pseudomonas aeruginosa Exotoxin A
  • Receptor, ErbB-2
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / pharmacology*
  • Recombinant Proteins
  • Transplantation, Heterologous
  • Virulence Factors*

Substances

  • Antibodies, Monoclonal
  • Bacterial Toxins
  • Carrier Proteins
  • DNA, Recombinant
  • Exotoxins
  • Immunotoxins
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • Recombinant Fusion Proteins
  • Recombinant Proteins
  • Virulence Factors
  • single-chain antigen-binding protein B6.2-212
  • ADP Ribose Transferases
  • Receptor, ErbB-2